MedPath
NMPA Approval

Mirabegron Sustained-release Tablets

国药准字H20243715

May 15, 2024

Drug Information

米拉贝隆缓释片

片剂

50mg

化学药品

May 15, 2024

Company Information

Applicant Company

江西省赣州经济技术开发区凤凰路116号

Manufacturing Company

江西省赣州经济技术开发区凤凰路116号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

米拉贝隆缓释片 - NMPA 批准文号 | MedPath